Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;23(28):1800341.
doi: 10.2807/1560-7917.ES.2018.23.28.1800341.

Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018

Affiliations

Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018

Cristina Domingo et al. Euro Surveill. 2018 Jul.

Erratum in

  • Authors' correction for Euro Surveill. 2018;23(28).
    Eurosurveillance editorial team. Eurosurveillance editorial team. Euro Surveill. 2018 Oct;23(40):1810042. doi: 10.2807/1560-7917.ES.2018.23.40.1810042. Euro Surveill. 2018. PMID: 30301491 Free PMC article. No abstract available.

Abstract

An external quality assessment of yellow fever virus (YFV) molecular detection in European laboratories was organised in rapid response to an increase in human cases in Brazil in 2018 with risk of import to Europe. Detection of YFV was assessed among 32 laboratories in 23/31 European Union (EU) and European Economic Area (EEA) countries and two laboratories in one non-EU/EEA country. Adequate capabilities were lacking in 10/23 countries; five did not participate as they lacked implemented assays.

Keywords: emerging or re-emerging diseases; imported viral diseases; laboratory surveillance; vector-borne infections; yellow fever virus.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure
Figure
Overview of the number of Emerging Viral Diseases-Expert Laboratory Network laboratories per country that participated in the yellow fever virus molecular external quality assessment, March 2018 (n = 34)

Similar articles

Cited by

  • Laboratory capacity assessments in 25 African countries at high risk of yellow fever, August-December 2018.
    Johnson BW, Demanou M, Fall G, Betoulle JL, Obiekea C, Basile AJ, Domingo C, Goodman C, Mossel E, Reusken C, Staples E, de Morais JFM, Neto Z, Paixão P, Denon YE, Glitho M, Mahinou J, Kagone T, Nakoune E, Gamougam K, Simbu EP, Ahuka S, Mombouli JV, Goma-Nkoua C, Adjogoua EV, Tayachew A, Beyene B, Sanneh B, Jarju ML, Mendy A, Amelor DK, Ofosu-Appiah L, Opare D, Antwi L, Adade R, Magassouba N, Gomes SF, Limbaso S, Lutomiah J, Gbelee B Jr, Dogba J, Cisse I, Idde Z, Ihekweazu C, Mba N, Faye O, Faye O, Sall AA, Koroma Z, Juma MA, Maror JA, Eldigail M, Elduma AH, Elageb R, Badziklou K, Komla KA, Kayiwa J, Lutwama JJ, Hampton L, Mulders MN. Johnson BW, et al. Pan Afr Med J. 2021 Apr 27;38:402. doi: 10.11604/pamj.2021.38.402.28886. eCollection 2021. Pan Afr Med J. 2021. PMID: 34381546 Free PMC article.
  • Assessing the risk of autochthonous yellow fever transmission in Lazio, central Italy.
    Manica M, Guzzetta G, Filipponi F, Solimini A, Caputo B, Della Torre A, Rosà R, Merler S. Manica M, et al. PLoS Negl Trop Dis. 2019 Jan 10;13(1):e0006970. doi: 10.1371/journal.pntd.0006970. eCollection 2019 Jan. PLoS Negl Trop Dis. 2019. PMID: 30629583 Free PMC article. No abstract available.
  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
    Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. Corman VM, et al. Euro Surveill. 2020 Jan;25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. Euro Surveill. 2020. PMID: 31992387 Free PMC article.
  • Yellow fever control: current epidemiology and vaccination strategies.
    Chen LH, Wilson ME. Chen LH, et al. Trop Dis Travel Med Vaccines. 2020 Jan 10;6:1. doi: 10.1186/s40794-020-0101-0. eCollection 2020. Trop Dis Travel Med Vaccines. 2020. PMID: 31938550 Free PMC article. Review.
  • What Does the Future Hold for Yellow Fever Virus? (II).
    Klitting R, Fischer C, Drexler JF, Gould EA, Roiz D, Paupy C, de Lamballerie X. Klitting R, et al. Genes (Basel). 2018 Aug 21;9(9):425. doi: 10.3390/genes9090425. Genes (Basel). 2018. PMID: 30134625 Free PMC article. Review.

References

    1. European Centre for Disease Prevention and Control (ECDC). Rapid Risk Assessment: Yellow fever among travellers returning from South America. Stockholm: ECDC; 2017. Available from: http://ecdc.europa.eu/en/publications/Publications/14-03-2017-RRA-Yellow...
    1. ProMED-mail YELLOW FEVER - NETHERLANDS: ex BRAZIL (SAO PAULO). Archive number. 20180115. 5561671 15 Jan 2018. Available from: http://www.promedmail.org
    1. Gossner CM, Haussig JM, de Bellegarde de Saint Lary C, Kaasik Aaslav K, Schlagenhauf P, Sudre B. Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, July 2017 to March 2018. Euro Surveill. 2018;23(11):1800106. 10.2807/1560-7917.ES.2018.23.11.18-00106 - DOI - PMC - PubMed
    1. Domingo C, Patel P, Yillah J, Weidmann M, Méndez JA, Nakouné ER, et al. Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol. 2012;50(12):4054-60. 10.1128/JCM.01799-12 - DOI - PMC - PubMed
    1. Patel P, Landt O, Kaiser M, Faye O, Koppe T, Lass U, et al. Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses. Virol J. 2013;10(1):58. 10.1186/1743-422X-10-58 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources